{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:33:36Z","timestamp":1786980816000,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908209"],"award-info":[{"award-number":["U1908209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170385"],"award-info":[{"award-number":["82170385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Previous studies investigating cardiac remodeling and functional regurgitation of rhythm control for atrial fibrillation (AF) in heart failure (HF) are limited. Therefore, this study aimed to evaluate the impact of rhythm control for AF on cardiac remodeling and functional regurgitation in the spectrum of HF. Its effect on prognosis was explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>According to the treatment strategies of AF, the cohort was classified into the rhythm control and rate control groups. To further detect the implications of rhythm control on cardiac remodeling, functional regurgitation, and outcomes in HF subtypes, patients were further divided into HF with reduced ejection fraction (HFrEF), HF with mildly reduced ejection fraction, and HF with preserved ejection fraction (HFpEF) subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 828 patients were enrolled, with 307 patients in the rhythm control group and 521 patients in the rate control group. Over a median follow-up time of 3.8 years, patients with rhythm control treatments experienced improvements in biatrial structure parameters, left ventricular ejection fraction, and functional regurgitation (mitral and tricuspid regurgitation) compared with rate control treatment (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Cox regression analysis demonstrated that rhythm control reduced the risks of all-cause mortality (HR 0.436 [95% CI, 0.218\u20130.871],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019) in HFpEF and HF-related admissions in HFrEF (HR 0.500 [95% CI, 0.330\u20130.757],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) and HFpEF (HR 0.541 [95% CI, 0.407\u20130.720],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001); these associations were similar after adjusting for multiple confounders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Rhythm control therapy can be considered an appropriate treatment strategy for the management of AF in HF to improve cardiac remodeling, functional regurgitation, and prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10557-023-07489-2","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T05:02:16Z","timestamp":1693371736000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of Rhythm Control for Atrial Fibrillation on Cardiac Remodeling and Valvular Regurgitation in Patients with Heart Failure"],"prefix":"10.1007","volume":"39","author":[{"given":"Jinping","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9385-992X","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"issue":"24","key":"7489_CR1","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.jacc.2012.06.062","volume":"60","author":"DL Mann","year":"2012","unstructured":"Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol. 2012;60(24):2465\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"7489_CR2","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-421.","journal-title":"J Am Coll Cardiol"},{"key":"7489_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","volume":"203","author":"D Kotecha","year":"2016","unstructured":"Kotecha D, Chudasama R, Lane DA, et al. Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes. Int J Cardiol. 2016;203:660\u20136.","journal-title":"Int J Cardiol"},{"issue":"5","key":"7489_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"7","key":"7489_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/CIRCRESAHA.122.320930","volume":"130","author":"OO Mesubi","year":"2022","unstructured":"Mesubi OO, Anderson ME. Heart Failure and Atrial Fibrillation-Chicken or Egg? Circ Res. 2022;130(7):1011\u20133.","journal-title":"Circ Res"},{"issue":"10","key":"7489_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.acvd.2019.06.010","volume":"112","author":"L Soulat-Dufour","year":"2019","unstructured":"Soulat-Dufour L, Lang S, Ederhy S, et al. Biatrial remodelling in atrial fibrillation: a three-dimensional and strain echocardiography insight. Arch Cardiovasc Dis. 2019;112(10):585\u201393.","journal-title":"Arch Cardiovasc Dis"},{"issue":"3","key":"7489_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.amjmed.2009.06.033","volume":"123","author":"PC Deedwania","year":"2010","unstructured":"Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: a comprehensive review. Am J Med. 2010;123(3):198\u2013204.","journal-title":"Am J Med"},{"issue":"6","key":"7489_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/heartjnl-2020-318081","volume":"108","author":"BA Mulder","year":"2022","unstructured":"Mulder BA, Rienstra M, Van Gelder IC, et al. Update on management of atrial fibrillation in heart failure: a focus on ablation. Heart. 2022;108(6):422\u20138.","journal-title":"Heart"},{"issue":"5","key":"7489_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417\u201327.","journal-title":"N Engl J Med"},{"issue":"14","key":"7489_CR10","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","volume":"143","author":"DL Packer","year":"2021","unstructured":"Packer DL, Piccini JP, Monahan KH, et al. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA Trial. Circulation. 2021;143(14):1377\u201390.","journal-title":"Circulation"},{"issue":"16","key":"7489_CR11","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","volume":"70","author":"S Prabhu","year":"2017","unstructured":"Prabhu S, Taylor AJ, Costello BT, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study. J Am Coll Cardiol. 2017;70(16):1949\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"7489_CR12","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1253\/circj.66.913","volume":"66","author":"X Zhou","year":"2002","unstructured":"Zhou X, Otsuji Y, Yoshifuku S, et al. Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. Circ J. 2002;66(10):913\u20136.","journal-title":"Circ J"},{"issue":"7","key":"7489_CR13","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777\u2013802.","journal-title":"J Am Soc Echocardiogr"},{"key":"7489_CR14","doi-asserted-by":"crossref","unstructured":"Kuck KH, Merkely B, Zahn R, et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol. 2019;12(12):e7731","DOI":"10.1161\/CIRCEP.119.007731"},{"issue":"1","key":"7489_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","volume":"7","author":"RJ Hunter","year":"2014","unstructured":"Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7(1):31\u20138.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"7489_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","volume":"144","author":"A Rillig","year":"2021","unstructured":"Rillig A, Magnussen C, Ozga AK, et al. Early rhythm control therapy in patients with atrial fibrillation and heart failure. Circulation. 2021;144(11):845\u201358.","journal-title":"Circulation"},{"issue":"17","key":"7489_CR17","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","volume":"359","author":"MN Khan","year":"2008","unstructured":"Khan MN, Ja\u00efs P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008;359(17):1778\u201385.","journal-title":"N Engl J Med"},{"issue":"3","key":"7489_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ejhf.1699","volume":"22","author":"M Tamargo","year":"2020","unstructured":"Tamargo M, Obokata M, Reddy Y, et al. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(3):489\u201398.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"7489_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.119.042996","volume":"141","author":"M Packer","year":"2020","unstructured":"Packer M, Lam C, Lund LH, et al. Interdependence of atrial fibrillation and heart failure with a preserved ejection fraction reflects a common underlying atrial and ventricular myopathy. Circulation. 2020;141(1):4\u20136.","journal-title":"Circulation"},{"issue":"10","key":"7489_CR20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","volume":"18","author":"A Goette","year":"2016","unstructured":"Goette A, Kalman JM, Aguinaga L, et al. EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18(10):1455\u201390.","journal-title":"Europace"},{"issue":"14","key":"7489_CR21","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.113.004742","volume":"129","author":"RP Martins","year":"2014","unstructured":"Martins RP, Kaur K, Hwang E, et al. Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation. Circulation. 2014;129(14):1472\u201382.","journal-title":"Circulation"},{"issue":"10","key":"7489_CR22","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2021.12.029","volume":"79","author":"L Soulat-Dufour","year":"2022","unstructured":"Soulat-Dufour L, Lang S, Addetia K, et al. Restoring sinus rhythm reverses cardiac remodeling and reduces valvular regurgitation in patients with atrial fibrillation. J Am Coll Cardiol. 2022;79(10):951\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"7489_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jchf.2019.03.005","volume":"7","author":"MA Carlisle","year":"2019","unstructured":"Carlisle MA, Fudim M, Devore AD, et al. Heart Failure and Atrial Fibrillation, Like Fire and Fury. JACC Heart Fail. 2019;7(6):447\u201356.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"7489_CR24","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/01.CIR.89.2.724","volume":"89","author":"SM Vaziri","year":"1994","unstructured":"Vaziri SM, Larson MG, Benjamin EJ, et al. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89(2):724\u201330.","journal-title":"Circulation"},{"issue":"1","key":"7489_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cpf.12595","volume":"40","author":"G Bajraktari","year":"2020","unstructured":"Bajraktari G, Byty\u00e7i I, Henein MY. Left atrial structure and function predictors of recurrent fibrillation after catheter ablation: a systematic review and meta-analysis. Clin Physiol Funct Imaging. 2020;40(1):1\u201313.","journal-title":"Clin Physiol Funct Imaging"},{"key":"7489_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fneur.2020.00026","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhao L, Zhang L, et al. Left atrial enlargement and the risk of stroke: a meta-analysis of prospective cohort studies. Front Neurol. 2020;11:26.","journal-title":"Front Neurol"},{"issue":"24","key":"7489_CR27","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1136\/heartjnl-2019-315174","volume":"105","author":"L Froehlich","year":"2019","unstructured":"Froehlich L, Meyre P, Aeschbacher S, et al. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105(24):1884\u201391.","journal-title":"Heart"},{"issue":"9","key":"7489_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/europace\/eun187","volume":"10","author":"H M\u00fcller","year":"2008","unstructured":"M\u00fcller H, Noble S, Keller PF, et al. Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation: evidence from real-time three-dimensional echocardiography. Europace. 2008;10(9):1073\u20138.","journal-title":"Europace"},{"issue":"1","key":"7489_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12968-020-00631-1","volume":"22","author":"E Xie","year":"2020","unstructured":"Xie E, Yu R, Ambale-Venkatesh B, et al. Association of right atrial structure with incident atrial fibrillation: a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA). J Cardiovasc Magn Reson. 2020;22(1):36.","journal-title":"J Cardiovasc Magn Reson"},{"key":"7489_CR30","doi-asserted-by":"crossref","unstructured":"Sohns C, Zintl K, Zhao Y, et al. Impact of left ventricular function and heart failure symptoms on outcomes post ablation of atrial fibrillation in heart failure: CASTLE-AF trial. Circ Arrhythm Electrophysiol. 2020;13(10):e8461","DOI":"10.1161\/CIRCEP.120.008461"},{"issue":"5","key":"7489_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/ejhf.2122","volume":"23","author":"H Sugumar","year":"2021","unstructured":"Sugumar H, Nanayakkara S, Vizi D, et al. A prospective study using invasive haemodynamic measurements following catheter ablation for AF and early HFpEF: STALL AF-HFpEF. Eur J Heart Fail. 2021;23(5):785\u201396.","journal-title":"Eur J Heart Fail"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-023-07489-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-023-07489-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T04:18:51Z","timestamp":1738815531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-023-07489-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7489"],"URL":"https:\/\/doi.org\/10.1007\/s10557-023-07489-2","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"assertion":[{"value":"7 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This is an observational study waived from ethics approval; all participants gave their consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors consent to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}